WILMINGTON, Del. -- To help frontline healthcare responders slow the spread of Severe Acute Respiratory Syndrome (SARS), DuPont today announced it has stepped up supply efforts for DuPont Tyvek protective disposable garments in mainland China and Hong Kong. In addition, DuPont has provided a financial contribution to assist in the battle against SARS in those locations.
In an effort to slow the spread of SARS, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have recommended detailed infection control methods, including the use of appropriate disposable protective garments and breathing equipment. DuPont is a leading global supplier of protective Tyvek disposable garments and fabrics.
Because of the SARS outbreak, China's government has requested 1 million protective Tyvek disposable garments for healthcare workers and other professionals. DuPont is working with partners around the world to provide the protective Tyvek garments to mainland China, Hong Kong and other locations as the need arises.
"DuPont is air freighting shipments of Tyvek products from around the world to the Asia Pacific region to meet initial demand," said DuPont Personal Protection Director of Sales and Operations Terry Stuchlik. "Additionally, we will utilize local and global production facilities to maximize product availability on an ongoing basis."
The structure of Tyvek flash-spun non-woven fabric provides a strong barrier against a range of microscopic substances -- including fine dusts, particles and fibers, as well as non-hazardous water-based liquids at low applied pressure. Tyvek is also extremely strong and tear-resistant.
The use of protective apparel in the CDC and WHO infection control procedures is to reduce the likelihood of skin contact with infectious materials, reduce transmission of the pathogens from patients to healthy individuals, and to permit health care workers to readily dispose of materials worn in the presence of known or suspected SARS patients. Disposal of garments may help contain the presence of infectious substances to designated areas within health care facilities, according to health care officials.
Long regarded as the leading expert in protective fabrics, DuPont provides products that are the industry leaders in the protective apparel and healthcare industries with its Sontara and Softesse medical fabrics and Tyvek disposable garments.
"It is important to note that protective garments are only part of a total system of precautions recommended by the CDC and WHO to address SARS," said DuPont personal protection researcher Jim Zeigler. "We hope the precautions and procedures recommended by these organizations help deter the spread of this disease as world health leaders search for more permanent solutions."
Source: DuPont
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.